fda compounding semaglutide enforcement november 2025 news September 15, 2025: Telehealth company must stop implying its compounded GLP-1 is FDA-approved, warns – Partnership for Safe Medicines Compounded "semaglutide" is not FDA-approved

U-100 insulin syringes are small-volume syringes with unit markings and attached needles, which is why they are often compared for peptide-related supply orders

References: IQVIA LAAD pharmacy claims data, US Market Access Strategy Consulting analysis Eli Lilly Tightens Access to Diabetes Drug, Frustrating Some People with Obesity, STAT News New Demand in an Old Market Read part 2 of this blog series to learn how the launch of Mounjaro transformed the GLP-1 market and led to the emergence of a new type of patient access profile thats challenging todays traditional diabetes care paradigm

The standard recommendation has been lifestyle changes, such as adopting a lower-calorie diet and increasing physical activity

And this is not super surprising when you think about it

The authors consensus identified relevant articles